齐鲁安替制药

Qilu Antie Pharmaceutical is a prominent Chinese pharmaceutical manufacturer specializing in the production of anti-infective active pharmaceutical ingredients (APIs), with a specific focus on sterile cephalosporins. As a key subsidiary of the Qilu Pharmaceutical Group, the company operates advanced manufacturing facilities that adhere to international quality standards, including certifications from the US FDA, EDQM, and PMDA. Its extensive product line includes widely used antibiotics such as Ceftriaxone Sodium, Cefotaxime Sodium, and Cefepime Hydrochloride, which are distributed globally. The company plays a vital role as a contract development and manufacturing organization (CDMO) for sterile powders, supporting the global supply of essential medicines. With a commitment to high-quality production, Qilu Antie has established itself as one of the world's largest production bases for cephalosporin APIs. The company exports its products to over 70 countries, maintaining a significant presence in regulated markets like the United States, Europe, and Japan.